SCHEMBL2003303

SCHEMBL2003303

CCN(C)Cc1cnn(-c2ccc(-c3ccc(F)cc3)cc2C)c1-c1ccco1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 1/20 0.38
KDM4E B2RXH2 2/20 0.36
HSD17B10 Q99714 2/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP2C19 P33261 1/20 0.36
RAB9A P51151 1/20 0.36
FLT3 P36888 1/20 0.35
MAPT P10636 3/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
TP53 P04637 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ADORA2A P29274 2/20 0.33
CYP3A4 P08684 1/20 0.32
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
PKM P14618 1/20 0.32
DNMT1 P26358 1/20 0.32
RECQL P46063 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1998525 0.83 HTR7 (0.39) HTR7KDM4EHSD17B10ALDH1A1CYP2C19
SCHEMBL1998756 0.83 NR3C1 (0.36) KDM4EHSD17B10ALDH1A1FLT3MAPT
SCHEMBL1998044 0.82 FLT3 (0.38) HSD17B10FLT3MAPTGRIN1GRIN2A
SCHEMBL1998680 0.81 HTR7 (0.39) HTR7KDM4EHSD17B10ALDH1A1CYP2C19
SCHEMBL2007394 0.79 PTGS1 (0.34) FLT3MAPTGRIN1GRIN2ATP53
SCHEMBL5227418 0.77 PTGS1 (0.38) KDM4EHSD17B10ALDH1A1CYP2C19RAB9A
SCHEMBL1998341 0.76 HTR7 (0.38) HTR7MAPTADORA2ACYP3A4
SCHEMBL5226500 0.75 PTGS1 (0.36) KDM4EHSD17B10ALDH1A1CYP2C19RAB9A
SCHEMBL1998214 0.75 LMNA (0.37) KDM4EALDH1A1ADORA2APOLBL3MBTL1
SCHEMBL5229165 0.74 FLT3 (0.37) KDM4EHSD17B10ALDH1A1RAB9AFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960413-B2 Pyrazole compounds MERCK PATENT GMBH (DE) 2011-06-14 US disclosed
EP-1611094-B1 PYRAZOLE COMPOUNDS MERCK PATENT GMBH (DE) 2007-06-20 EP disclosed
US-20060276650-A1 Pyrazole compounds MERCK PATENT GMBH (DE) 2006-12-07 US disclosed
EP-1611094-A1 PYRAZOLE COMPOUNDS MERCK PATENT GmbH (DE) 2006-01-04 EP disclosed
WO-2004089888-A1 PYRAZOLE COMPOUNDS MERCK PATENT GMBH (DE) 2004-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276650-A1 Pyrazole compounds HTR1D, HTR1A, HTR3A HTR7 16/4885KDM4E 3986/4885HSD17B10 3259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.